Evaluating the safety of Bactiseal Catheters in hydrocephalus patients
Official title: A Multi-center, Retrospective Registry Study on the Safety of Bactiseal Catheter
Run by Integra LifeSciences Corporation · NCT06276543 · Data updated 2026-11-12
This study is trying to see if the Bactiseal catheter, used for managing hydrocephalus, is safe and helps prevent infections in patients who had it implanted.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Integra LifeSciences Corporation Industry-sponsored |
| Locations | 8 sites (Beijing, Beijing Municipality and 7 other locations) |
| Status | Recruiting |
| Started | September 29, 2024 |
| Main results expected | July 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 27, 2025 |
| Trial ID | NCT06276543 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients who have had a Bactiseal catheter implanted for hydrocephalus for at least two years.
✕Probably not a fit
Patients who are allergic to components of the Bactiseal catheter or have existing infections at the implant site may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the safety of the Bactiseal catheter, an antibiotic-impregnated device used for hydrocephalus management. It will retrospectively enroll 200 subjects who had the catheter implanted between January 1, 2019, and June 30, 2022, collecting data on adverse events and infections over a two-year period. Information will be gathered from medical records regarding the subjects' general condition, intraoperative details, and any complications encountered. The study is designed to provide insights into the effectiveness and safety of this catheter in preventing infections.
Why it matters
Potential benefit: If successful, this study could enhance the safety and effectiveness of hydrocephalus treatment by reducing infection rates associated with catheter use.
How similar studies have gone: While this study focuses on a specific catheter, similar studies evaluating antibiotic-impregnated devices have shown promising results in reducing infection rates.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The informed consent is exempted by the Ethics Committee of a research center. Or a subject or his/her legal representative signed the informed consent form (ICF) prior to the enrollment. 2. A subject had an indication suitable to use Bactiseal Catheter. 3. A subject implanted hydrocephalus shunt catheter for at least 2 years at the time of enrollment. Exclusion Criteria: 1. A subject didn't have an indication suitable to use the catheter. 2. A subject was known to be allergic to a component or ingredient of the catheter to be implanted, including silicone catheter, rifampicin, and clindamycin. 3. According to the comprehensive judgment of an investigator, a subject had an infection of the implant site when the shunt is implanted, such as ventriculitis, meningitis, peritonitis, and local implant skin infection. 4. A subject was simultaneously implanted with another shunt catheter different from Bactiseal Catheter. 5. A subject had a contraindication of the shunt operation. 6. A subject had uncorrected coagulopathy or any bleeding disorder.
Where it's running
-
the 2nd Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China Recruiting -
the Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China Recruiting -
Shanghai Children's Medical Center affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China Recruiting -
West China Hospital of Sichuan University
Chengdu, Sichuan, China Recruiting -
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China Completed -
Beijing Hospital
Beijing, Beijing Municipality, China Completed
Show 2 more locations
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China Completed -
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China Completed
Study contacts
- Principal investigator: Nan Bao, MD — Shanghai Children's Medical Center Affiliated to Shanghai Jiaotong University School of Medicine
- Study coordinator: Hua Tang, MD
- Email: hua.tang@integralife.com
- Phone: 0086 21-63179772
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wearable sensor to detect CSF flow in shunt tubing
This will test a small, wireless skin sensor to see if it can detect cerebrospinal fluid (CSF) flow through implanted shunts in children and adults with stable hydrocephalus.
-
CSF lactate and other biomarkers in patients with an external ventricular drain after acute brain injury
This project will test whether changes in cerebrospinal fluid lactate and other blood/CSF biomarkers can help detect ventriculostomy-associated infection in adults with acute brain injury who have an external ventricular drain.
-
See if a wireless thermal device can measure CSF shunt flow during daily activities and sleep
A wireless thermal device is being tested to see if it can non-invasively monitor CSF shunt flow in people with hydrocephalus during everyday activities and sleep.
-
Evaluating a device for measuring cerebrospinal fluid flow and headaches
This study is testing a new device that measures the flow of cerebrospinal fluid in people with hydrocephalus to see if it can help understand their headaches better.
-
Understanding brain and heart injuries after bleeding in the brain
This study looks at how bleeding in the brain affects both the brain and the heart in adults to better understand the connection between these injuries.
-
Light therapy for severe neonatal brain bleeding
This study is testing if a special light therapy can help newborns with severe brain bleeding feel better and develop normally over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.